| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT04632433 | Neoadjuvant Plus Adjuvant Treatment With Cemiplimab in Cutaneaous Squamous Cell Carcinoma | Cutaneous Squamous Cell Carcinoma | Active, Not Recruiting |
| NCT04722575 | Combination or Sequence of Vemurafenib, Cobimetinib, and Atezolizumab in High-risk… | Melanoma | Active, Not Recruiting |
| Not specified | |||
| NCT06880198 | Study to Evaluate Impact® as Support to Anti PD1 or Anti PD1 Based Regimen Treatment in… | Melanoma Metastatic | Recruiting |